INTRODUCTION {#SEC1}
============

Somatic mutations are the predominant cause of cell cycle dysregulation and unrestrained proliferation that occurs during the development of sporadic cancers. Recently, members of the apolipoprotein B mRNA editing enzyme catalytic polypeptide-like (APOBEC) family of cytidine deaminases have been identified as tumor-specific sources of DNA damage ([@B1],[@B2]) occurring in ∼15% of human cancers ([@B3]--[@B5]). The catalytically active enzymes in this family, which include activation-induced cytidine deaminase (AID), APOBEC1 and the seven APOBEC3 enzymes (A through H), all deaminate cytidines in single-strand (ss) DNA substrates resulting in cytidine (C) to thymidine (T) or C to guanidine (G) substitutions ([@B3]--[@B5]). Additionally, every active APOBEC family member except AID and APOBEC3G (A3G) deaminate cytidines specifically within T[C]{.ul}W motifs (where the underlined C is deaminated and W = adenine (A) or T) ([@B6]). This nucleotide editing capacity normally is used to tailor immunoglobulin affinities (AID) ([@B7]), alter apolipoproteins involved in dietary lipid transport (APOBEC1) ([@B8]) and as an anti-viral/retrotransposon innate immune response (APOBEC1 and APOBEC3) ([@B6]).

Initial characterization of the role APOBECs play in cancer have relied primarily on the over-representation of APOBEC signature mutations in cancer genomes and characteristic patterns among these mutations in relationship to various chromosomal features. A large portion of the experimental data supporting that these patterns are consistent with APOBEC activity has been accumulated in yeast and other model systems. Studies aimed at understanding AID\'s involvement in somatic hypermutation and class switch recombination uncovered a strong preference for this enzyme to deaminate cytidine in the non-transcribed strand of genes ([@B9]--[@B12]). Based on extrapolation of this specificity, other APOBEC enzymes were initially proposed to likewise edit cancer genomes by deaminating transcription bubbles. While some evidence for non-AID APOBECs editing transcription intermediates has been observed in yeast and bioinformatics analysis of some human cancers ([@B13]--[@B15]), APOBEC deamination of other ssDNA substrates has been additionally uncovered. The formation of APOBEC-induced clustered mutations, called kataegis, has been linked to the ability of these enzymes to deaminate chromosomal ssDNA intermediates formed during 5΄ to 3΄ resection at double-stranded breaks (DSBs) ([@B16]). More recently, publications have determined in yeast and *Escherichia coli* that the lagging strand template during DNA replication is the primary chromosomal substrate of several members of the APOBEC3 subfamily, including APOBEC3A (A3A), APOBEC3B (A3B) and A3G ([@B17],[@B18]). Likewise, induction of DSBs by over-expression of A3A in U2OS cells requires DNA replication, implicating the lagging strand template is an APOBEC substrate in human cells ([@B19]). Multiple analyses of the distribution of APOBEC signature mutations in human tumors also indicate that deamination at replication forks is the primary means for these enzymes to mutagenize cancer genomes ([@B20]--[@B22]), and supports the usage of yeast and other organisms as a model for studying how APOBEC enzymes contribute to cancer generation. Cytidine deamination ahead of nascent DNA synthesis by the lagging strand polymerase results in deoxyuridine (dU) templating for A insertion and consequently results in C to T substitutions (or G to A substitutions if the dU is formed on the complementary DNA strand) if left unprocessed. How the mutagenic consequences of cytidine deamination in replication-associated ssDNA are mitigated is currently unclear.

In humans and yeast, dU incorporated into double-stranded (ds) DNA is removed by base excision repair (BER). In yeast, this mechanism involves the excision of the uracil base by the Ung1 uracil glycosylase, generation of a nick 5΄ of the newly formed abasic site by Apn1, strand displacement DNA synthesis by polymerase δ to replace the damaged base, flap removal and finally ligation by DNA Ligase I ([@B23]). However, during replication the ssDNA that serves as a substrate for APOBEC-induced deamination may not be ideal for repair by this mechanism as a nick in the phosphodiester backbone following conversion of dU to an abasic site would generate a DSB. Despite this, robust repair of these deamination events seems to occur, as indicated by an increase in APOBEC-induced mutagenesis as the consequence of *UNG1* deletion ([@B16],[@B18],[@B24],[@B25]). Furthermore, the generation of γ-H2AX foci by over-expression of A3A in human cells ([@B19],[@B26],[@B27]) suggests further BER activities may occur in ssDNA, namely APE1-mediated cleavage of Ung-generated abasic sites. Replication forks may stall at Ung-generated abasic sites and subsequently regress, returning the abasic site into dsDNA ([@B23]). This would then allow normal BER to repair dU lesions in a pre-replicative manner ([@B28]). Alternatively, any of three DNA damage tolerance (DDT) pathways could be utilized to bypass the Ung-generated abasic sites ([@B23]). Usage of these pathways is regulated by specific post-translational modifications to the PCNA sliding clamp in response to fork-stalling lesions at the replication fork ([@B29],[@B30]). This includes SUMOylation by Siz1-Ubc9 to regulate recombination-mediated fork restart ([@B23],[@B31]), monoubiquitination by Rad18-Rad6 to signal for translesion synthesis (TLS) ([@B31]--[@B33]), or polyubiquitination by Rad5-Ubc13-Mms2 to signal for error-free template switching ([@B29],[@B34]).

Here, we show that yeast use a lesion-conversion mechanism ahead of DNA strand synthesis to avoid mutagenic A3B-induced dU during DNA replication. This conversion is done through Ung1-mediated excision of dU generating a fork-stalling abasic site, which is then circumvented primarily by the error-free bypass pathway. Deletion of *UBC13, MMS2*, or *MPH1* (all genes critical for error-free bypass) increase the *CAN1* mutation frequency induced by A3B activity to levels approaching *ung1*Δ strain frequencies. In contrast, deletion of individual BER components *APN1, APN2, NTG1, NTG2*, or other DDT components *REV3* and *SIZ1*, had little effect on replication-associated mutagenesis. This indicates that the downstream steps of BER, TLS and recombination-mediated fork restart play more limited roles in preventing A3B-induced mutations.

Additionally, we found that error-free lesion bypass requires Ubc13 in a replication-specific manner, as *ubc13*Δ does not affect the frequency of *CAN1* mutations incurred during the re-synthesis of uncapped telomeres, despite Mph1-mediated error-free bypass of similar abasic sites still occurring. Interestingly, analyses of the *CAN1* mutation spectra in both replicative and telomere re-synthesis systems indicate that Ubc13 and Mms2 play a significant role in determining which TLS polymerase is active in bypassing abasic sites, as the *ubc13*Δ and *mms2*Δ spectra had diminished numbers of G to C substitutions indicative of the activity of the TLS polymerase, Rev1. This suggests that Ubc13 and Mms2 promote Rev1 cytidine transferase activity during TLS-mediated abasic site bypass and play a unique role in the crosstalk between error-free lesion bypass and TLS pathways. These results indicate that robust error-free lesion bypass mechanisms may significantly mitigate the deleterious effects of APOBEC-induced damage in human cancers and enable continued cell proliferation despite high levels of DNA damage occurring within the replication fork.

MATERIALS AND METHODS {#SEC2}
=====================

Yeast culture and strains {#SEC2-1}
-------------------------

Yeasts were grown using standard techniques ([@B35]) on standard rich media (YPDA) or synthetic complete (SC) media. All haploid strains utilized in this study were constructed by recombination-directed chromosomal integration in the CG379 genetic background, a derivative of S288C *Saccharomyces cerevisiae* ([@B36]). The genotypes of each strain used are listed in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}. Briefly, novel gene deletion yeast strains were produced by transformation with polymerase chain reaction (PCR) fragments containing either a nourseothricin resistance cartridge (NAT-R) or a geneticin resistance cartridge (G418-R) flanked by sequences homologous to the wild-type gene. The primers used to generate these fragments are listed in [Supplementary Table S2](#sup1){ref-type="supplementary-material"}. The transformed yeast strains were selected for on appropriate drug-supplemented media. Diploid yeast heterozygous for a chromosomally integrated A3B-HygR (hygromycin resistance) expression construct and/or *rad5*Δ were generated by mating haploid MATα *rad5*Δ strains to either haploid MATa wild-type yeast or to haploid MATa strains containing A3B-HygR integrated into *LEU2* on Chr III. Six independent crosses using three *rad5*Δ isolates and two A3B+ strains were conducted. Single colonies were isolated by streaking onto YPDA, isolates patched out onto YPDA plates and phenotype verified using selective media.

Plasmid transformation of yeast {#SEC2-2}
-------------------------------

Yeast clonal isolates were grown to saturation in liquid standard rich media (YPDA) at either 23°C for *cdc13-1* strains or 30°C for all other strains, followed by a 3--5 h secondary incubation at appropriate temperatures. The yeasts were transformed with either A3B-expression or vector-control plasmids containing a hygromycin resistance cartridge ([@B18]) and were grown on YPDA overnight before replica plating to YPDA media supplemented with hygromycin (300 μg/ml) for selection of the plasmid.

Plating efficiency and growth kinetics of yeasts expressing A3B {#SEC2-3}
---------------------------------------------------------------

Yeast strains used in this study ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}) were transformed with either A3B-expression or vector-control plasmids and streaked to obtain clonal single cell isolates. Six independent isolates from each genotype were resuspended in water, counted and plated on YPDA supplemented with hygromycin (300 μg/ml) at a density of ∼200 cells per plate. Following a three-day incubation period at 30°C, the number of colonies growing on the plates were counted and compared to the number of cells plated to determine the median plating efficiency for each genotype. Alternatively, six single colony isolates of the wild-type yeasts were isolated following transformation with A3B-expressing or vector-control plasmid, resuspended in water and counted. 15 ml YPDA was then inoculated with 1.5 × 10^4^ cells and incubated at 30°C. The O/D600 of these cultures was measured at 2-h intervals for 17 h.

Tetrad dissection and plating efficiency of *rad5*Δ yeast expressing A3B {#SEC2-4}
------------------------------------------------------------------------

Verified diploid strains heterozygous for an integrated A3B expression construct and/or *rad5*Δ were grown on sporulation media (20 g/l KAc, 1 g/l yeast extract, 20 g/l agar) for 5 days (1 day at 30°C and 4 days at room temperature). Resulting tetrads were re-suspended in water and treated with zymolyase for 10 min to digest the outer cell wall, prior to dissection on YPDA using a Singer MSM400. After 3 days of growth, tetrad dissections were replica plated to YPDA, YPDA supplemented with G418 (200 μg/ml), and YPDA supplemented with hygromycin (300 μg/ml) to assess the genotype of individual spores. The distribution of genotypes between large and small colonies was compared by two-tailed chi-squared goodness-of-fit test. Cells from 10--15 independent spores for each genotype resulting from the dissection were then re-suspended, counted and plated on YPDA media at a density of 200 cells per plate. After three days growth at 30°C the number of colonies growing on YPDA plates were counted and compared to the number of cells plated to determine the plating efficiency for each genotype.

Determination of mutation frequency {#SEC2-5}
-----------------------------------

Yeast freshly transformed with either an A3B-expression or vector-control plasmid were streaked for single colonies. Independent colonies were re-suspended in water, diluted, and plated at a density of 200 cells per plate on YPDA supplemented with hygromycin. Transformed yeast containing *CAN1* on Chr II were grown at 30°C for 72 h to accumulate mutations. Six or seven independent clones were selected, re-suspended, and plated to SC media lacking arginine and supplemented with 0.006% canavanine and also plated to nonselective SC media at appropriate concentrations to determine mutation frequencies. Mutation frequencies were assessed as a ratio of yeast colonies that gain canavanine resistance to the number of colonies that grow in the absence of selection, corrected by the respective dilution factors and calculated using the following formula: $$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}\begin{equation*}\begin{array}{@{}*{1}{l}@{}} {{\rm Mutation}\;{\rm Frequency} = }\\ {\frac{{(\# \;{\rm Ca}{{\rm n}^R}{\rm Colonies})\,({\rm Dilution}\;{\rm plated}\;{\rm on}\;{\rm canavanine}\;{\rm supplemented}\;SC -{\rm Arg}\;{\rm media})}}{{(\# \;{\rm Colonies}{\rm }\;{\rm on}\;SC\;{\rm media})\,({\rm Dilution}\;{\rm plated}\;{\rm on}\;SC\;{\rm media})}}} \end{array}\end{equation*}\end{document}$$

Can^R^ frequencies for *cdc13-1* yeast containing *CAN1* in the Chr V sub-telomere were measured as previously described in detail ([@B37]). Briefly, yeast clonal isolates containing the *cdc13-1* allele, the Chr V *CAN1* mutation reporter and either the vector control or A3B-expression plasmid were grown at 23°C to saturation, followed by a 1:10 dilution and a second incubation at 37°C (the non-permissive temperature for the *cdc13-1* allele) for 6 h to expose ssDNA through telomere uncapping and end resection. Cells were then appropriately plated as described above to determine mutation frequencies. Differences in mutation frequency between genotypes were evaluated statistically using a two-tailed Mann--Whitney rank sum test in Graphpad Prism5 (Graphpad, La Jolla, CA, USA). All mutation frequency values are listed in [Supplementary Table S3](#sup1){ref-type="supplementary-material"}.

Evaluation of mutation spectra {#SEC2-6}
------------------------------

Yeast transformed with A3B-expressing plasmid were plated on YPDA supplemented with hygromycin (300 μg/ml) at a density of ∼200 cells per plate and grown for three days at 30°C to accumulate mutations within independent colonies, after which they were replica plated to SC-arginine media supplemented with 0.006% canavanine and grown for an additional three days to select for Can^R^ yeast. Alternatively, following a 6 h incubation at 37°C, cultures of *cdc13-1* yeast transformed with A3B were directly plated to SC-arginine media supplemented with 0.006% canavanine and allowed to grow four days at 23°C to obtain Can^R^ isolates. Independent Can^R^ papillae were then selected and further clonally isolated through single colony streaking. Genomic DNA was isolated by bead agitation in a LiAc/SDS/TE buffer and purified over OMEGA HiBind DNA mini columns (Omega Bio-tek, Inc., Norcross, GA, USA). The *CAN1* gene in isolates from wild-type, *ubc13*Δ, *mph1*Δ, *ung1*Δ, *ubc13*Δ *mph1*Δ, *ubc13*Δ *ung1*Δ and *mph1*Δ *ung1*Δ genetic backgrounds were PCR amplified using primers with unique identification barcodes listed in [Supplementary Table S2](#sup1){ref-type="supplementary-material"}. These amplicons were pooled and sequenced by SMRT sequencing on a PacBio RSII as in ([@B38]). We obtained a total of 6197 consensus sequence reads, each obtained by at least three complete passages of an individual DNA fragment. This equated to 2--63× coverage per barcoded amplicon. The sequencing results were sorted into individual isolates identified by their unique identification barcode combination. Consensus sequence reads were assembled to the reference *CAN1* gene and mutations called in Geneious 8.1.8 (Biomatters Limited, Newark, NJ, USA). All called mutations were supported by multiple aligned circular consensus sequences (CCS) and occurred in greater than 50% of aligned reads per unique barcode set. The *CAN1* gene from *mms2*Δ and *apn1*Δ *apn2*Δ yeast strains were PCR amplified using alternative primers listed in [Supplementary Table S2](#sup1){ref-type="supplementary-material"} and Sanger sequenced (Genscript Biotech Corporation, Piscataway, NJ, USA) as described in ([@B18]). Statistical significance for strand bias or nucleotide insertion preference was determined using a G-test of goodness-of-fit. Comparisons between mutation spectra of different genotypes were evaluated using a two-tailed Fisher\'s exact test in Graphpad Prism5 (Graphpad, La Jolla, CA, USA). The preferred nucleotide sequences mutated in *CAN1* following A3B expression were generated with the mutated base +/− 1 nt using WebLogo (<http://weblogo.berkeley.edu/logo.cgi>) as described in ([@B39]). All mutations identified through sequencing are listed in [Supplementary Table S4](#sup1){ref-type="supplementary-material"} and summaries of the mutation spectra are provided in [Supplementary Table S5](#sup1){ref-type="supplementary-material"}.

RESULTS {#SEC3}
=======

A3B-induced deaminations are converted to abasic sites by Ung1, but not repaired through the BER pathway {#SEC3-1}
--------------------------------------------------------------------------------------------------------

To address how APOBEC-induced dU that occur in the context of DNA replication are repaired or otherwise processed, we ectopically expressed A3B within strains of *Saccharomyces cerevisiae* and measured *CAN1* forward mutations, which result in canavanine resistance (Can^R^), using a reporter on chromosome II located 16 kb centromere proximal of ARS216. We previously showed that A3B-induced mutations in this location are primarily due to deamination occurring in ssDNA during the synthesis of the lagging strand (Figure [1A](#F1){ref-type="fig"}) ([@B18]). Consistent with our previous findings, A3B expression in this system had no detectable effect on the growth kinetics of wild-type yeast ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}) but resulted in ∼200-fold increase in mutation frequency compared to vector-only controls (Figure [2A](#F2){ref-type="fig"}). Deletion of *UNG1* in A3B-expressing strains caused an additional 8.5-fold increase in mutation frequency, indicating that A3B-induced dU is either repaired or bypassed in an error-free manner during DNA replication. To test whether abasic sites created by Ung1-catalyzed removal of dU in ssDNA at the replication fork are moved into dsDNA through fork regression and subsequently repaired by BER, we deleted the *APN1, APN2, NTG1* and *NTG2* genes which encode the yeast AP endonucleases and AP lyases known to participate in BER ([@B23]) (Figure [2A](#F2){ref-type="fig"}). The deletion of *APN1* in the vector-transformed strain showed increases in mutation frequency as a result of impaired BER activity, indicating that this deletion removes the majority of AP endonuclease activity in yeast. However, the independent deletion of *APN1* or any other BER endonuclease or lyase in the A3B-expressing strains failed to significantly increase the Can^R^ frequency beyond wild-type levels. To determine whether redundant activity between these enzymes may enable efficient removal of A3B-induced lesions and thereby obscure mutagenic effects in the single deletion strains, we measured Can^R^ frequency in *apn1*Δ *apn2*Δ and *ntg1*Δ *ntg2*Δ double deletion strains. Yeast where both *NTG1* and *NTG2* were deleted demonstrated only a small 1.8-fold increase in Can^R^ frequency compared to wild-type yeast, further supporting that these lyases play little role in the repair of abasic sites in replication-associated ssDNA. In contrast, *apn1*Δ *apn2*Δ strains displayed a moderate 2.8-fold increase in Can^R^.

![Reporters used in this study. (**A**) The *CAN1* forward mutation reporter was placed 16 kb centromere proximal to the replication origin ARS216 on Chr II. This system has been previously shown to accumulate mutations predominantly through A3B-induced deamination during replication. During DNA replication the lagging strand template is exposed to A3B, resulting in targeted dC to dU deamination. This confers a mutation in *CAN1* which allows the yeast to survive on selective canavanine media. Based upon the location of *CAN1* to the centromere proximal side of ARS216, the bottom DNA strand of the gene is the lagging strand template. Thus, cytidine deamination occurs on the bottom strand, resulting in mutations at G bases (sequencing reports mutations relative to the top DNA strand). (**B**) The *CAN1* forward mutation reporter was placed 7.5 kb from the end of the telomere of Chr V. This system contains the *cdc13-1* mutant allele which uncaps telomeres at nonpermissive temperatures and halts the growth of *Saccharomyces cerevisiae* at G~2~ phase following DNA replication. Following telomere uncapping, 5΄ to 3΄ resection initiates, resulting in the exposure of dC in ssDNA to A3B. When sequenced, the mutations in the re-synthesized strand are reported as mutations in dG.](gkx169fig1){#F1}

![BER is not a predominant method of removing A3B-induced dU formed during replication. (**A**) The frequencies of canavanine-resistance (Can^R^) induced in WT, *ung1*Δ, *apn1*Δ, *apn2*Δ, *apn1Δ apn2Δ, ntg1*Δ, *ntg*2Δ and *ntg1*Δ *ntg*2Δ yeast following transformation with vector control plasmid, or A3B expression plasmid were assessed. Can^R^ frequency was determined in isogenic strains harboring the *CAN1* reporter on Chr II. Horizontal bars and numeric values indicate the median frequency of six independent replicates. Statistical significance was determined by a two-tailed non-parametric Mann--Whitney rank sum test. (**B**) The strand bias of *CAN1* mutations from A3B-expressing wild-type, *apn1*Δ *apn2*Δ and *ung1*Δ yeast strains were assessed by Sanger sequencing. The mutation spectra frequency represents the proportion of the Can^R^ frequency in (A) that can be attributed to the individual mutation types. The numerical values above the bars indicate the number of mutations in each strand for each strain. Statistical significance of strand bias in each genotype was determined by a two-tailed G-test of goodness-of-fit. \*\*:*P* \< 0.02.](gkx169fig2){#F2}

To understand the cause of mutation in these strains, we sequenced the *CAN1* gene in independent Can^R^ clones. Consistent with previous results showing that A3B targets the lagging strand template during DNA replication ([@B18]), we observed predominantly G bases mutated within [G]{.ul}A dinucleotides (complementary to T[C]{.ul}) in the wild-type and the *UNG1* deficient strains (*P* \< 0.002) (Figure [2B](#F2){ref-type="fig"} and [Supplementary Figure S2A--D](#sup1){ref-type="supplementary-material"}). However, the *apn1*Δ *apn2*Δ strains displayed a significant loss of this strand bias (Figure [2B](#F2){ref-type="fig"}). The frequency of G mutations that potentially originate from deamination of ssDNA in the lagging strand template in *apn1*Δ *apn2*Δ strains increased only 1.3-fold compared to the G mutation frequency in wild-type yeast (Figure [2B](#F2){ref-type="fig"} and [Supplementary Table S5B](#sup1){ref-type="supplementary-material"}). In contrast, C mutations in *apn1*Δ *apn2*Δ strains increased 4.7-fold. This change in mutation spectrum in *apn1*Δ *apn2*Δ strains indicates that instead of the increase in mutagenesis stemming from failure to remove A3B lesions on the lagging strand template, it occurs due to the presence of additional mutagenic A3B-induced lesions formed on the leading strand template. These added lesions likely originate from increased ssDNA substrate generated as a consequence of an inability to effectively remove spontaneous base lesions. Accordingly, vector-transformed *apn1*Δ *apn2*Δ strains showed a significant (p-0.0260 versus wild-type) decrease in survival ([Supplementary Figure S3A](#sup1){ref-type="supplementary-material"}), indicating the yeast\'s compromised capacity to process spontaneous lesions creates difficulties during cell division. These results therefore suggest that while Ung1-mediated dU removal occurs in ssDNA, the downstream mechanisms in BER are likely not prominently involved in the processing of A3B-induced deaminations that occur during DNA replication. Thus, pre-replicative repair of these lesions by BER is not a major mechanism for avoiding APOBEC-induced mutations. The apparent inability of AP endonucleases to mediate BER of A3B-induced lesions during replication could result from ssDNA binding proteins sterically blocking the access of these enzymes to abasic sites in the lagging strand template. Alternatively, human APE1 was previously shown biochemically to have drastically reduced affinity for abasic sites in ssDNA compared to dsDNA ([@B40]), indicating that the ssDNA context of these lesions itself may make them resistant to repair.

A3B-induced deaminations are predominantly bypassed by error-free damage avoidance {#SEC3-2}
----------------------------------------------------------------------------------

Since BER processes downstream of dU excision by Ung1 do not reduce A3B-induced mutations, other mechanism(s) must act to mitigate some or all of the mutational consequences of cytidine deamination during replication. Therefore, we sought to determine if DDT pathways are utilized to bypass abasic sites generated following excision of A3B-induced dU by Ung1 (Figure [3](#F3){ref-type="fig"} and [Supplementary Figure S4A](#sup1){ref-type="supplementary-material"}). To specifically assess the contribution of TLS to A3B-induced mutagenesis, we deleted the catalytic subunit of the TLS DNA polymerase ζ (*REV3*), which is required for all damage-induced mutagenesis in yeast ([@B23]). We observed no notable change in mutation frequency or cell survival when ectopic A3B is expressed in *rev3*Δ strains(Figure [3B](#F3){ref-type="fig"} and [Supplementary Figure S3B and C](#sup1){ref-type="supplementary-material"}), indicating that TLS does not play a major role in damage avoidance of A3B-induced dU at the replication fork.

![Error-free bypass is the DDT pathway used to avoid A3B-induced lesions incurred ahead of polymerase δ lagging strand DNA synthesis. (**A**) Possible mechanisms for processing dU and their mutagenic outcomes. If left within DNA, the A3B-induced dU will confer a G to A mutation due to templating during replication, as indicated in black. Glycolytic removal of the uracil base by Ung1, converts dU to an abasic site, which can then serve to induce DNA damage tolerance (DDT) pathways to bypass the lesion. Specific modifications on the PCNA clamp determine pathway choice. PCNA SUMOylation by Ubc9-Siz1 controls recombination-mediated fork restart, noted in red. Monoubiquitination of PCNA by Rad18-Rad6 can result in two outcomes: the initiation of TLS and the insertion of untemplated nucleotides across from the abasic site (purple) or the extension of the ubiquitin chain by Rad5-Ubc13-Mms2 (blue). The latter results in the initiation of error-free lesion bypass. (**B** and **C**) Frequencies and mutational spectra of Can^R^ following transformation with A3B expression plasmid assessed in yeast strains harboring the *CAN1* reporter on Chr II were assessed. (B) *rev3*Δ, *siz1*Δ, *ubc13*Δ, *mms2*Δ, *mph1*Δ and *mte1*Δ yeast strains were compared to discern the usage of the various DDT pathways to avoid abasic sites generated during replication. Horizontal bars and numerical values indicate the median frequency of six or seven independent replicates. Statistical significance was determined by a two-tailed non-parametric Mann-Whitney rank sum test. WT and *ung1Δ* values from Figure [2](#F2){ref-type="fig"} are included for reference. (C) The mutation spectra of the *CAN1* in independent WT, *ubc13*Δ, *mms2*Δ or *ung1*Δ Can^R^ yeast were determined through PacBio and Sanger Sequencing. The mutation spectra frequency represents the proportion of the Can^R^ frequency in (A) that can be attributed to the individual mutation types. The numerical values above the bars indicate the number of isolates with the reported mutation. Statistical significance of G to A and G to C mutation ratios in each genetic backgrounds were determined by two-tailed G-test of goodness-of-fit test. \*:*P* \< 0.05, \*\*: *P* \< 0.01.](gkx169fig3){#F3}

Next, we deleted genes involved in post-translational modifications of the PCNA clamp used to signal for individual DDT pathway selection. While no notable change in mutation frequency or cell survival was observed in the *siz1*Δ strain (Figure [3B](#F3){ref-type="fig"} and [Supplementary Figure S3B and C](#sup1){ref-type="supplementary-material"}), the deletion of *UBC13* resulted in a 4.9-fold increase in Can^R^ over wild-type (*P* = 0.0022). These mutation frequencies indicate that recombination-mediated fork restart does not have a major role in lesion avoidance during replication. Instead, the mutagenic consequences of APOBEC-induced dU are primarily bypassed through an error-free template switching mechanism. Supporting this, deletion of *MMS2*, another member of the Rad5-Ubc13-Mms2 E3 ubiquitin ligase complex involved in the polyubiquitination of PCNA, increased *CAN1* mutagenesis 2.8-fold over the wild-type (*P* = 0.0022). We also deleted *RAD5*, the third member of the Rad5-Ubc13-Mms2 E3 ligase complex, but attempts to transform this strain with A3B-expressing plasmid consistently failed, suggesting a synthetic lethal phenotype may exist in A3B-expressing *rad5*Δ strains. To test this, we generated *rad5*Δ strains containing a chromosomally integrated A3B expression construct through mating, sporulation and tetrad dissection. We observed a slow-growth phenotype specifically in *rad5*Δ spores expressing A3B. Dilution and plating of ∼200 individual *rad5*Δ A3B+ cells on rich media demonstrated a decrease in plating efficiency ([Supplementary Figure S5](#sup1){ref-type="supplementary-material"}), indicating that the combination of *RAD5* loss and A3B expression does result in cell death. This severe phenotype is likely due to greater difficulty bypassing abasic sites and completing replication as Rad5 plays roles in both initiating error-free lesion bypass and stimulating Rev1-mediated TLS ([@B41]).

To further confirm Rad5-Ubc13-Mms2 signaling of error-free bypass of abasic sites as the favored mechanism for circumventing A3B-induced mutation, we also deleted *MPH1*, which encodes a helicase involved in the error-free template switching pathway ([@B42]) (Figure [3B](#F3){ref-type="fig"}). The loss of the Mph1 helicase also increased A3B-induced Can^R^ frequency 7.8-fold over wild-type (*P* = 0.0034) and nearly to the level associated with *ung1*Δ, suggesting that in the absence of Mph1 all A3B-induced lesions become mutagenic. Mph1 is a multifunctional protein with roles in homologous recombination ([@B43]), telomere maintenance ([@B44]), Okazaki fragment maturation ([@B45]), as well as error-free lesion bypass ([@B42],[@B46]). To determine whether inability of Mph1 to mediate its functions during homologous recombination contributes to the observed elevation in A3B-induced Can^R^ frequency in *mph1*Δ strains, we deleted the Mph1-associated factor Mte1, which supports Mph1 activities during the homology-directed repair of DNA double strand breaks ([@B47]--[@B49]). No detectable difference was observed between the Can^R^ frequency of *mte1*Δ strains compared to wild-type yeast (*P* = 0.0931). Thus, the increased mutagenicity of A3B activity in *mph1*Δ strains is unlikely to be due to a defect in homology-directed repair, and the increase in Can^R^ observed with the *MPH1-*deficient strains are likely due the defects in the helicase\'s role in error-free bypass. Supporting this, the mutation frequency in strains deficient in both *UBC13* and *MPH1* are similar to *mph1*Δ single mutant strains (*P* = 0.0129 versus *ubc13*Δ), indicating that Ubc13-mediated bypass occurs as a subset of Mph1-mediated bypass ([Supplementary Figure S6](#sup1){ref-type="supplementary-material"}). No detectable difference in mutation frequency was observed between *ubc13*Δ *ung1*Δ*, mms2*Δ *ung1*Δ*, or mph1*Δ *ung1*Δ strains and *ung1*Δ strains ([Supplementary Figure S7B](#sup1){ref-type="supplementary-material"}), verifying that with respect to A3B-induced mutation, *UBC13, MMS2* and *MPH1* are epistatic with *UNG1*. A small, but statistically significant difference in mutation frequency was observed between *mph1*Δ and *mph1*Δ *ung1*Δ strains (*P* = 0.038) as well as between *ubc13*Δ and *ubc13*Δ *ung1*Δ strains (*P* = 0.005).

We then sequenced the *CAN1* gene in independent Can^R^ clones to assess the mutation spectra in error-free lesion bypass-deficient yeast (Figure [3C](#F3){ref-type="fig"}). As with the wild-type and *UNG1*-deficient strains, we observed predominantly G bases mutated within [G]{.ul}A dinucleotides (complementary to T[C]{.ul}) ([Supplementary Figure S2A--C, E--J and S8](#sup1){ref-type="supplementary-material"}), indicating that unlike A3B-induced mutations in *apn1*Δ *apn2*Δ strains, the elevated mutations in bypass-deficient yeast result from inability to tolerate lesions in the lagging strand template in an error-free manner. Additionally, all strains deficient in Ung1 had solely G to A mutations due to retention of dU in the DNA ([Supplementary Figure S7C](#sup1){ref-type="supplementary-material"}), further confirming that these mutations result from A3B-induced deamination.

Previous reports have shown *CAN1* mutations induced by A3G activity on ssDNA at uncapped telomeres ([@B37]) or APOBEC-attributed mutations in human cancer ([@B3],[@B5]) consisted of equal amounts of G to A and G to C substitutions. This substitution pattern occurs due to abasic site bypass by the TLS polymerase, Rev1, which exclusively inserts C across from abasic sites, and a second polymerase which primarily inserts A (termed A-rule insertion) ([@B37]). However, the *CAN1* mutation spectra induced by A3B activity during replication of wild-type yeast in our study consisted of almost exclusively G to A mutations (*P* = 0.000019) (Figure [3C](#F3){ref-type="fig"}). This result is consistent with previous analyses of A3B-induced mutation in yeast ([@B16],[@B18]) and is likely because the majority of mutations in wild-type yeast result from residual dU that template C to T substitutions. Accordingly, the A3B-induced Can^R^ frequency in the *rev3*Δ strain is similar to the wild-type strain (Figure [3B](#F3){ref-type="fig"}), indicating that most A3B mutations in wild-type yeast are generated independently of TLS. However, in strains lacking error-free template switching, the majority of A3B-induced mutations are due to error-prone TLS past abasic sites. This is evident as deletion of *REV3* in the *ubc13*Δ and *mph1*Δ strains decreased the APOBEC-induced mutation frequency to wild-type levels in addition to demonstrating a decreased cell survival (Figure [4](#F4){ref-type="fig"}, [Supplementary Figures S3B, C and S4B](#sup1){ref-type="supplementary-material"}). The A3B-induced *CAN1* mutation spectrum in *mph1*Δ strains has nearly equal representation of G to C and G to A substitutions (Figure [3B](#F3){ref-type="fig"}), demonstrating the usage of Rev1 and another 'A-rule' polymerase in the bypass of abasic sites. The polymerase responsible for this untemplated A-rule insertion is likely either polymerase δ or ζ, as both have been previously shown biochemically to preferentially insert deoxyadenine across from an abasic site ([@B50]), the lesions are lagging strand specific, and DNA polymerase η has previously been shown to contribute little to mutagenic abasic site bypass ([@B37]). Interestingly, the *ubc13*Δ and *mms2*Δ mutation spectra consisted predominantly of G to A mutations (*P* = 0.000136 and *P* = 0.033, respectively), indicating that abasic site bypass in these strains is accomplished primarily by A-rule insertion at the abasic site followed by polymerase ζ mediated extension past the lesion. Since Rev1 has been shown to be required for damage-induced mutagenesis as a structural component ([@B37],[@B51],[@B52]) and the *CAN1* mutation frequency increases in *ubc13*Δ and *mms2*Δ strains, this result cannot be explained by a failure to recruit Rev1 to abasic sites. Therefore, Ubc13 and Mms2 appear to directly promote nucleotide insertion by Rev1 during abasic site TLS bypass.

![Mutagenesis in error-free bypass-deficient strains is TLS-dependent. A3B-induced Can^R^ frequencies WT, *rev3*Δ, *ubc13*Δ, *ubc13*Δ *rev3*Δ, *mph1*Δ and *mph1*Δ *rev3*Δ yeast. Can^R^ frequency was determined with *CAN1* reporter on Chr II. Values for WT, *rev3*Δ, *ubc13*Δ and *mph1*Δ from Figure [3](#F3){ref-type="fig"} are included for reference. Horizontal bars and numeric values indicate the median frequency of six or seven independent replicates. Statistical significance was determined by a two-tailed non-parametric Mann--Whitney rank sum test.](gkx169fig4){#F4}

Usage of Ubc13 in error-free damage avoidance is context-specific {#SEC3-3}
-----------------------------------------------------------------

Although most DNA synthesis occurs during replication, gap-filling synthesis without canonical replication forks can occur during restoration of uncapped telomeres or DSB repair. If damage accumulates in the exposed ssDNA formed during these processes, usage of error-free bypass with non-allelic templates could result in genetic rearrangements as a consequence of close proximity to a DNA terminus in the template strand. To test whether error-free bypass is used to avoid damage during non-replicative DNA synthesis, we assessed the effect of Ubc13 and Mph1 deficiency on A3B-induced mutagenesis in a yeast strain with a *cdc13-1* allele that results in telomere uncapping and subsequent 5΄ to 3΄ resection of the chromosome end under non-permissive temperatures. This resection renders the *CAN1* gene susceptible to A3B-induced deamination due to its location 7.5 kb from the chromosome V end (Figure [1B](#F1){ref-type="fig"}) ([@B37]). As the result of telomere uncapping, *cdc13-1* yeast grown at non-permissive temperature arrest in G~2~ phase of the cell cycle ([@B53]). Upon return to permissive growth temperatures, non-replicative DNA synthesis occurs to restore the resected chromosome ends, and any lesions encountered by this process could potentially utilize the available sister chromatid as a template for error-free bypass.

Within this system, we observed a 6.1-fold increase in the Can^R^ frequency upon expressing A3B compared to the vector-only controls. Furthermore, deletion of *UNG1* resulted in an additional 7.3-fold increase in Can^R^ (*P* = 0.0022), showing that dU excision is involved in the avoidance of mutation during non-replicative DNA synthesis (Figure [5A](#F5){ref-type="fig"}) as it is during replicative DNA synthesis. In contrast to APOBEC-induced *CAN1* mutagenesis during replication, *rev3*Δ resulted in a 95% reduction in the Can^R^ frequency compared to the *cdc13-1* strain (*P* = 0.0012). This result indicates that a significant amount of A3B-induced mutations during telomere re-synthesis are mediated through error-prone bypass of abasic sites by TLS, confirming previous studies assessing A3G mutagenesis in the same system ([@B37]). Additionally, we observed an increase in the Can^R^ frequency in the *cdc13-1 mph1*Δ strains, demonstrating that these lesions are also bypassed in an error-free manner. Surprisingly, the *cdc13-1 ubc13*Δ strain failed to significantly alter the Can^R^ frequency compared to *cdc13-1* strains, indicating that the polyubiquitination of PCNA may not be required for error-free damage avoidance during gap-fill DNA synthesis. This difference in mutation frequency between the *UBC13*- and *MPH1*-deficient strains may suggest that licensing of pathway initiation may be dispensable for error-free bypass during certain types of gap-fill synthesis.

![Ubc13 is dispensable for error-free bypass of abasic sites in non-replicative DNA synthesis but plays a role in Rev1 usage. Frequencies and mutational spectra of Can^R^ following transformation with vector control plasmid, or A3B expression plasmid assessed in yeast strains harboring the *CAN1* reporter on Chr V. (**A**) *cdc13-1, cdc13-1 ung1*Δ, *cdc13-1 mph1*Δ, *cdc13-1 rev3*Δ and *cdc13-1 ubc13*Δ yeast strains were assessed to discern the usage of the error-free bypass pathway to avoid abasic sites generated during nonreplicative DNA synthesis. Horizontal bars and numerical values indicate the median frequency of six or seven independent replicates. Statistical significance was determined by a two-tailed non-parametric Mann--Whitney rank sum test. (**B**) The mutation spectra of the *CAN1* in independent *cdc13-1, cdc13-1 ung1*Δ and *cdc13-1 ubc13*Δ Can^R^ yeast were assessed through PacBio sequencing. The mutation spectra frequency represents the proportion of the Can^R^ frequency in (A) that can be attributed to the individual mutation types. The numerical values above the bars indicate the number of isolates with the reported mutation. Statistical significance of G to A and G to C mutation ratios between genetic backgrounds were determined by two-tailed Fisher\'s exact test.](gkx169fig5){#F5}

Next, we determined the roles of individual TLS polymerases in abasic site bypass by sequencing the *CAN1* gene from independent Can^R^ mutants from the *cdc13-1, cdc13-1 ubc13*Δ and *cdc13-1 ung1*Δ strains (Figure [5B](#F5){ref-type="fig"}). Mutations in *CAN1* were strand biased consisting primarily of mutations in G bases within [G]{.ul}A dinucleotides ([Supplementary Figures S2A, K--N and S8](#sup1){ref-type="supplementary-material"}), consistent with A3B deamination only occurring in the DNA strand remaining following 5΄ to 3΄ resection from the uncapped telomere. Additionally, *cdc13-1 ung1*Δ strains predominantly contained G to A substitutions (*P* = 0.000144) (Figure [5B](#F5){ref-type="fig"}), further supporting that A3B-induced dU is the primary lesion occurring in these yeast. A3B induced an equal number of G to A and G to C substitutions in *cdc13-1* strains, similar to previously reported mutation spectra for A3G-induced mutations in this system and is reminiscent of APOBEC-induced human cancer mutation spectra. This contrasts with our observation in the wild-type replicative strain, which displayed a strong bias (*P* = 0.000019) towards G to A mutations due to dU retention. This difference may be explained by a greater efficiency of dU being converted to abasic sites in the telomere re-synthesis system due to extended holding of the yeast at non-permissive temperatures, which may give Ung1 more opportunity to excise the dU. Interestingly, the *cdc13-1 ubc13*Δ strain demonstrated a substantial decrease in G to C substitutions compared to the *cdc13-1* strain (*P* = 0.0252). This result indicates that despite its dispensability for error-free lesion bypass during telomere re-synthesis, Ubc13 still promotes Rev1 usage during TLS in this system in a similar fashion as during replicative DNA synthesis.

DISCUSSION {#SEC4}
==========

In this study, we demonstrate in *S. cerevisiae* that A3B-induced dU lesions formed in ssDNA of the lagging strand template are avoided in a two-step lesion conversion and bypass mechanism (Figure [6](#F6){ref-type="fig"}). First, the dU lesions are efficiently converted to abasic sites by Ung1 ahead of DNA synthesis by the replicative polymerase. These abasic sites serve to stall the replicative polymerase and induce a template switching mechanism to bypass the majority of the lesions in an error-free manner (Figure [3B](#F3){ref-type="fig"}). Ablation of the error-free bypass pathway leads to an increase in Can^R^ frequency, which is the result of error-prone nucleotide insertion across from the abasic site in a TLS-dependent manner (Figure [4](#F4){ref-type="fig"}). Surprisingly, deleting *UBC13* or *MMS2*, traditional components promoting error-free bypass, reduced G to C substitution in the *CAN1* gene mutation spectrum from an equal representation of G to A and G to C mutations(Figure [3C](#F3){ref-type="fig"}). This indicates that Ubc13 and Mms2 may moderate TLS polymerase usage through controlling Rev1 cytidine transferase activity. We observed a similar decrease in G to C substitution in the absence of Ubc13 during uncapped telomere re-synthesis, even though this deletion resulted in no detectable impact on mutation frequency, (Figure [5](#F5){ref-type="fig"}) indicating the ubiquitin ligase still directs TLS polymerase usage even when the protein is dispensable for error-free bypass.

![Model for avoidance of APOBEC-induced lesions ahead of lagging strand DNA synthesis. (**A**) Single stranded DNA in the lagging strand template contain cytidines susceptible for APOBEC-induced deamination. These dU are excised by Ung1 ahead of the replicative polymerase, generating a fork-stalling abasic site (denoted as AP). The majority of these lesions are bypassed in an error-free manner by template switching, which is dependent on Ubc13, Mms2, Rad5 and Mph1. Some abasic sites are bypassed via the error-prone TLS pathway, dependent on Rev1 and polymerase ζ. Here, Ubc13 and Rad5 influence polymerase choice by promoting Rev1-mediated dC insertion, resulting in G to C substitutions. Alternatively, A-rule insertion by a different polymerase results in G to A substitutions. (**B**) Following end resection, cytidines on the non-resected DNA strand are exposed to APOBEC activity. These dU are excised by Ung1, generating abasic sites. During gap-fill synthesis, the polymerase stalls at the abasic sites. At this point, the lesion is predominantly bypassed through Mph1-dependent error-free template switch, potentially using its sister chromatid as a template or through error-prone TLS, dependent on Rev1 and polymerase ζ. As with (A), Ubc13 promotes Rev1 cytidine transferase activity during TLS, however, Ubc13-mediated polyubiquitination of PCNA is unnecessary for initiating error-free template switching.](gkx169fig6){#F6}

In human cells, Ung2, the human nuclear equivalent to yeast Ung1, travels with the replication fork ([@B54]), presumably to remove dU incorporated into newly synthesized DNA by replicative polymerases. Our results indicate that Ung1 can also work ahead of polymerase δ to convert spontaneous or A3B-induced dU to abasic sites prior to DNA synthesis. A consequence of this lesion conversion is the stalling of the replication fork as polymerase δ encounters these sites ([@B55]). However, contrary to previous reports in mammalian cells of glycosylases converting base lesions to abasic sites to initiate fork regression and subsequent pre-replicative DNA repair, our results in yeast indicate that the PCNA clamp is polyubiquitinated by the Rad5-Ubc13-Mms2 E3 ligase complex to initiate error-free bypass ([@B32],[@B56]). This bypass may involve the use of an alternative template for DNA synthesis directly at the replication fork. Alternatively, DNA synthesis may reinitiate downstream of the lesion, leaving the modified PCNA clamp as a marker for error-free postreplicative repair ([@B29]) after DNA replication completes. This mechanism of lesion conversion and bypass may be used to avoid mutagenesis stemming from other ssDNA-specific DNA damage at the replication fork.

The conversion of A3B-induced dU to abasic sites ahead of DNA polymerase δ lagging strand synthesis enables us to semi-quantitatively compare the relative contribution of error-free bypass and TLS in abasic site bypass in eukaryotic chromosomal DNA. Since *ubc13*Δ and *mph1*Δ strains have similar TLS-dependent increases in Can^R^ frequencies, we conclude that most, if not all, TLS bypass events of abasic sites derived from cytidine deamination are mutagenic. Therefore, we can utilize the Can^R^ frequencies in strains deficient for error-free bypass and TLS as a surrogate for the relative usage of each DDT pathway. In the replicative system, we see that error-free bypass is used approximately 17.4- to 21.3-fold more than TLS (the ratio of usage between error-free bypass and TLS calculated as: $\documentclass[12pt]{minimal}
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}{}$\frac{{fmph1\Delta\;or\;ubc13\Delta - f{\rm WT}}}{{f{\rm WT} - fmph1\Delta \;rev3\Delta\ or\;ubc13\Delta \;rev3\Delta}}$\end{document}$ using fluctuation values) for the *UBC13* and *MPH1* deficient strains, respectively. Similarly, error-free bypass is predominant over TLS even during telomere re-synthesis, occurring 3.5-fold more frequently than TLS. Predominant usage of error-free bypass usage is consistent with recent findings showing RecA-dependent damage avoidance mechanisms are favored in chromosomal lesion bypass in *E. coli* ([@B57]). This suggests that prokaryotes and eukaryotes use similar mechanisms to avoid fork stalling DNA lesions. Whether template switching mechanisms are used to bypass lesions occurring in human cells, which restrict the use of recombination-based mechanisms of DNA repair, is unknown.

The relationship between error-free bypass and TLS appears to be more complicated than simply two alternative mechanisms that enable continued replication when DNA polymerases are confronted with fork-stalling DNA lesions. Recent studies have begun to uncover direct crosstalk between the two mechanisms, mediated by the Rad5-Ubc13-Mms2 ubiquitin ligase complex that polyubiquitinates PCNA to initiate error-free lesion bypass. We have uncovered additional evidence of this crosstalk in the A3B-induced mutation spectra of *ubc13*Δ and *mms2*Δ yeast. The deletion of *UBC13* or *MMS2* resulted in an under-representation of TLS-mediated G to C substitutions, indicating reduced usage of Rev1 cytidine transferase activity to bypass abasic sites in favor of an A-rule insertion polymerase. The Rad5-Ubc13-Mms2 E3 ligase complex was previously reported to associate directly with Rev1 through Rad5 and indirectly with polymerase ζ through Rev1 ([@B41],[@B58]). Disruption of the Rev1-Rad5 binding domain results in sensitivity to DNA damaging agents and reduced damaged-induced mutagenesis, consistent with the loss of both error-free lesion bypass and TLS, presumably due to the inability to recruit Rev1 to lesions sites. A3B-expression in *rad5*Δ yeast produces a similar reduced cell viability ([Supplementary Figure S5](#sup1){ref-type="supplementary-material"}), indicating that Rad5 likely also promotes both error-free bypass and TLS past abasic sites ahead of polymerase δ lagging strand synthesis during replication. Supporting this interpretation, A3B expression in *ubc13*Δ *rev3*Δ and *mph1*Δ *rev3*Δ yeast which lack both TLS and error-free bypass reduces cell survival ([Supplementary Figure S3B and C](#sup1){ref-type="supplementary-material"}). In contrast, the reduction of Rev1-induced mutations in the *ubc13*Δ strains is unlikely to be due to failure to recruit Rev1, as this enzyme is structurally required for TLS and thus its absence should eliminate all TLS synthesis. Thus, we propose that Ubc13 directly promotes Rev1 cytidine transferase activity.

In human cancers and yeast, APOBEC enzymes target lagging strand synthesis intermediates during replication. The mutation spectra for APOBEC-mutagenized tumors show an equal representation in G to C and G to A substitutions, indicating the usage of TLS, partially attributable to Rev1, in the bypass of abasic sites as the primary mediators of APOBEC-induced mutagenesis. However, in wild-type yeast, we observed that the vast majority of A3B-induced abasic sites were bypassed in an error-free manner during replication, with remaining mutagenic lesions consisting of unexcised dU resulting in G to A substitutions. Multiple explanations could account for this difference in mutation spectra between human cancers and replicating yeast expressing A3B. The first and simplest explanation would be that human cells utilize TLS at a higher frequency to bypass abasic sites than yeast, or error-free bypass may be downregulated or dysfunctional in cancer cells. Alternatively, replication stress, which occurs in human cancers, may result in dysregulated DNA synthesis that is more akin to yeast gap-fill synthesis. Here, an increased amount of ssDNA ahead of the replicative polymerase may enable Ung to excise dU at a higher efficiency. This would act to decrease the proportion of mutations resulting from dU templating relative to those resulting from insertion by TLS. We were able to estimate the amount of dU that is retained in the DNA in each system by comparing the estimated contributions in bypassing dU by TLS and error-free bypass to the mutation frequency observed by deleting *UNG1*. In the replicative system, we estimate that Ung1 was ∼90.1% efficient at excising dU $\documentclass[12pt]{minimal}
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\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$( {\frac{{fcdc13-1 ung1\Delta - fcdc13-1 rev3\Delta }}{{fcdc13-1 ung1\Delta }};\frac{{5.56x{{10}^{ - 3}} - 4.25x{{10}^{ - 5}}}}{{5.56x{{10}^{ - 3}}}}x100\% } )$\end{document}$. This difference in Ung1 efficiency alone between the two systems would add approximately 12-fold more G to A mutations due to dU templating to the *CAN1* mutation spectrum of the replicative system in comparison to that of the telomere re-synthesis system. This would ultimately result in a strong bias towards G to A substitutions over G to C substitutions, irrespective of an altered relative usage of error-free lesion bypass and TLS. If indeed the bulk of APOBEC-induced dU in human cancer is bypassed in an error-free manner as we see in yeast, our findings suggest that the true number of APOBEC-induced damages to the DNA may be much greater than previously estimated from the amount of APOBEC signatures observed in cancer genomic sequences.
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